← SynDRA
OLVEREMBATINIB
SynDRA canonical compound SYN0036650 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ABL1 | BCR |
| Mechanism of action | Bcr-Abl kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- ABL1 INHIBITOR
- Bcr-Abl kinase inhibitor
- Inhibitor
Cross-references
Synonyms
- HQP1351
- Olverembatinib dimesylate
- D-824
- D-824 DIMESYLATE
- GZD-824
- GZD-824 DIMESYLATE
- HQP-1351
- HQP-1351 DIMESYLATE
- HQP1351 DIMESYLATE
- GZD824
- 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
- UNII-KV1M7Q3CBP
- KV1M7Q3CBP
- 4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide
- CHEMBL2316582
- Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-
- 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{1H-pyrazolo[3,4-b]pyridin-5-yl}ethynyl)benzamide
- Benzamide, 4-methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-
- HQP1351 free base
- HQP-1351 free base
- SCHEMBL3424528
- GTPL10630
- EX-A829
- AOB87323
- BCP07502
- BDBM50425780
- ZINC95594040
- AKOS026750647
- CS-1444
- SB16617
- compound 10a [PMID: 23301703]
- NCGC00351607-06
- AK547162
- AS-75170
- HY-15666
- FT-0700150
- A16264
- W-6136
Look up OLVEREMBATINIB in the interactive SynDRA portal →